Purchase Order 75N95022P00078

Award Date 1/4/22
Potential Completion Date 1/3/23
Potential Value $82K
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Dallas, TX 75207, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse awarded a firm fixed-price purchase order to Stratasys, Inc., a foreign-owned, for-profit manufacturer, to provide an FDM 3D printer for $160,154.55. The contract has a completion date of November 11, 2020. The printer will be used to support the engineering and fabrication needs of the Section on Instrumentation group. The contract is not set aside for small businesses. Stratasys, Inc....
The National Institute of Biomedical Imaging and Bioengineering, a civilian agency, awarded a $24,500 firm-fixed-price purchase order contract to 3D Systems, Inc., a for-profit manufacturing organization, for the delivery of a 3D bioprinter. The contract has a period of performance through June 30, 2025 and does not utilize any set-aside designations. 3D Systems has a history of providing 3D printing solutions and services to various federal agencies, including the Department of Defense, NASA,...
This firm-fixed-price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health, National Institute of Environmental Health Sciences to Stratasys, Inc. to provide a 3D printer for the agency's intramural research program. The contract has a potential value of $127,300.00 and a completion date of August 29, 2021. Stratasys, Inc. is a foreign-owned, for-profit manufacturer of industrial 3D printing and additive manufacturing solutions. The company has...
This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the National Institutes of Health (NIH), to Stratasys, Inc., a foreign-owned for-profit manufacturer of industrial 3D printing and additive manufacturing solutions. The contract provides for the delivery of an Objet260 Connex 3 3D printer, with no set-aside designation. The total ceiling value of the award is $92,150.00, with a completion date of November 30, 2020. The...
This firm fixed-price purchase order contract was awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to 3D Systems, Inc. for a preventative maintenance and service agreement for a 3D Systems Project 6000 printer. The contract, valued at $79,654.52, will provide maintenance and support services to ensure the printer remains operational to support NIDA's rapid prototyping and manufacturing needs, particularly for MRI-compatible parts and...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $230,620 purchase order to Cimquest Inc. to procure an XM200G 3D printer. As the prime contractor, Cimquest will deliver the requested 3D printing system to support research efforts. Performance will take place at Cimquest's New Jersey facility over approximately two months. No subcontractors or set aside designations were indicated. This award advances the NIH's mission to...
Stratasys, Inc. was awarded a $101,165.50 firm fixed price purchase order by the National Institutes of Health's National Center for Advancing Translational Sciences to provide a Stratasys J5 MediJet 3D printer. The biocompatible polyjet 3D printer will be utilized to support the NIH's efforts in advancing biomedical research and development. Place of performance will be in Potomac, Maryland. The single award was made on July 3, 2023 with work to be completed by August 2, 2023. No set aside...
The National Institute of Biomedical Imaging and Bioengineering, a civilian federal agency, awarded a $46,183.84 firm-fixed-price purchase order to Stratasys, Inc., a foreign-owned for-profit manufacturer of industrial 3D printing solutions. The contract is for the maintenance of a Polyjet J826 Prime 3D printer and does not have a set-aside designation. Stratasys has secured numerous federal awards to provide specialized 3D printing systems, maintenance services, and related equipment to support...
This is a fixed-price purchase order awarded by the National Institute of Mental Health, a civilian federal agency, to B9Creations, LLC, a veteran-owned small business manufacturer, for the delivery of a 3D printer. The contract is valued at $19,790.55 and has an ultimate completion date of October 31, 2024. No set-aside was used for this award. This contract may be part of a larger indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle managed by the National Institute of Mental...
This firm fixed-price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Cellink LLC, a foreign-owned for-profit biotech company based in Germany. The $85,489.00 contract is for the procurement of a BIONOVA X 3D bioprinter and associated software, bioink, warranty, and installation/training services. This requirement was a streamlined solicitation for commercial items with...

The National Center for Advancing Translational Sciences, a civilian agency, awarded a $81,528.37 firm-fixed-price purchase order to 3Dgence America Inc. for the procurement of an industrial high-temperature 3D printer. This award did not have a set-aside designation. 3Dgence America Inc. is a for-profit manufacturer of 3D printing and additive manufacturing equipment. The National Center for Advancing Translational Sciences is part of the National Institutes of Health and is focused on advancing the translation of scientific discoveries into clinical applications. This 3D printer purchase is likely to support the agency's research and development activities involving prototyping or production capabilities.

Generated 4/3/25, 1:02 AM